Total Liabilities: The total value of all possible claims against the corporation.
Organogenesis (ORGO) had Total Liabilities of $275.44M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$37.23M |
|
$-56.16M |
|
$25.77M |
|
$11.46M |
|
$106.12M |
|
$-68.89M |
|
$0.42M |
|
$-68.47M |
|
$-68.47M |
|
$-53.16M |
|
$-53.16M |
|
$-53.16M |
|
$-53.16M |
|
$-68.89M |
|
$-56.52M |
|
127.80M |
|
127.80M |
|
$-0.44 |
|
$-0.44 |
|
| Balance Sheet Financials | |
$268.50M |
|
$104.08M |
|
$251.49M |
|
$519.99M |
|
$76.02M |
|
$12.36M |
|
$199.42M |
|
|
Total Liabilities |
$275.44M |
$244.56M |
|
$212.35M |
|
$244.56M |
|
128.68M |
|
| Cash Flow Statement Financials | |
$21.13M |
|
$-3.15M |
|
$-20.21M |
|
$94.33M |
|
$92.10M |
|
$-2.23M |
|
$3.64M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.53 |
|
-- |
|
-- |
|
0.05 |
|
0.05 |
|
30.77% |
|
-185.05% |
|
-185.05% |
|
-- |
|
-183.93% |
|
-150.85% |
|
$17.98M |
|
-- |
|
-- |
|
-- |
|
0.07 |
|
0.91 |
|
0.32 |
|
282.63 |
|
-21.74% |
|
-25.03% |
|
-10.22% |
|
-20.69% |
|
$1.90 |
|
$0.14 |
|
$0.17 |
|